Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. FUJIFILM Holdings Corporation
  6. News
  7. Summary
    4901   JP3814000000

FUJIFILM HOLDINGS CORPORATION

(4901)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fujifilm : Launches Virtual Hospital to Showcase that it's Comprehensive Healthcare Portfolio is Committed to Enhancing Patient Care

07/14/2021 | 09:25am EDT

Lexington, Mass., USA, July 14, 2021 (GLOBE NEWSWIRE) -- Fujifilm today announced the launch of the Fujifilm Virtual Hospital. The virtual hospital presents visitors with an interactive environment where they can view and learn about Fujifilm’s robust portfolio of healthcare solutions, and discover how the company’s diagnostic, treatment and research technologies advance the entire continuum of patient care.

The launch of the Virtual Hospital follows the completion of Fujifilm’s acquisition of Hitachi’s diagnostic imaging business, now called FUJIFILM Healthcare Americas Corporation. Today, Fujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development.

“With a steadfast mission to never stop innovating for a healthier world, Fujifilm continues to make major strides in expanding our depth and breadth in healthcare, catering to the evolving needs of healthcare professionals and our patients,” Hidetoshi Izawa, Vice President of Modality Solutions and In-Vitro Diagnostics at FUJIFILM Medical Systems U.S.A., Inc., and Executive Vice President of Business integration at FUJIFILM Healthcare Americas Corporation. “As our ways of interacting continue to evolve as a result of COVID-19, our Fujifilm Virtual Hospital creates a unique experience to introduce our full portfolio of solutions and services, access clinical and educational content and understand the interconnectivity of our healthcare solutions.”

On the initial opening of the Fujifilm Virtual Hospital, a helpful pop-up with instructions will help visitors navigate a self-guided tour of the Virtual Hospital. Visitors can also request a virtual or in-person demonstration to learn more about specific offerings by clicking on contact us on any of the product detail pages.

Users can explore the interactive Fujifilm Virtual Hospital today by clicking here.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It’s ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse® Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. Fujifilm’s in vitro diagnostics (IVD) portfolio includes clinical lab reagents, and biomarkers to assess the risk for the development of hepatocellular carcinoma in patients with chronic liver disease. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit  https://healthcaresolutions-us.fujifilm.com/.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com

 


Marissa ConfredoFujifilm
914-343-4761
marissa.confredo@fujifilm.com
Source: FUJIFILM Holdings America Corporation

2021 GlobeNewswire, Inc., source Press Releases

All news about FUJIFILM HOLDINGS CORPORATION
09/22FUJIFILM : The premium compact digital camera “FUJIFILM X100V” wins Bronze Awa..
PU
09/21APPILI THERAPEUTICS : Announces Agreement with FUJIFILM and Funding Support for Clinical T..
AQ
09/21FUJIFILM : Two Fujifilm Leaders Recognized as “Women Worth Watching” by Profil..
AQ
09/21FUJIFILM : North America Corporation Celebrates Newest FUJIFILM Creators
AQ
09/20APPILI THERAPEUTICS : Up 1% as Secures US$1 Million from FUJIFILM to Support Clinical Tria..
MT
09/20APPILI THERAPEUTICS : Secures US$1 Million from FUJIFILM to Support Clinical Trials for An..
MT
09/06FUJIFILM : Launches LTO Ultrium9 Data Cartridge -Magnetic tape storage media with maximum ..
PU
09/02Peptidream to Acquire Fujifilm Toyama Chemical's Radiopharmaceutical Business
MT
09/02FUJIFILM : launches FUJINON Lens GF35-70mmF4.5-5.6 WRá(Fujifilm)
PU
09/02FUJIFILM : launches mirrorless digital camera “FUJIFILM GFX50S II”á(Fujifilm)
PU
More news
Financials
Sales 2022 2 499 B 22 596 M 22 596 M
Net income 2022 172 B 1 559 M 1 559 M
Net Debt 2022 228 B 2 065 M 2 065 M
P/E ratio 2022 22,7x
Yield 2022 1,09%
Capitalization 3 915 B 35 363 M 35 404 M
EV / Sales 2022 1,66x
EV / Sales 2023 1,60x
Nbr of Employees 73 275
Free-Float 73,9%
Chart FUJIFILM HOLDINGS CORPORATION
Duration : Period :
FUJIFILM Holdings Corporation Technical Analysis Chart | 4901 | JP3814000000 | MarketScreener
Technical analysis trends FUJIFILM HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 9 792,00 JPY
Average target price 10 057,14 JPY
Spread / Average Target 2,71%
EPS Revisions
Managers and Directors
Teiichi Goto President, CEO & Representative Director
Kenji Sukeno Chairman
Takashi Iwasaki Director & Chief Technology Officer
Kunitaro Kitamura Independent Outside Director
Tatsuo Kawada Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
FUJIFILM HOLDINGS CORPORATION80.07%35 363
ABBOTT LABORATORIES13.59%220 485
MEDTRONIC PLC11.00%174 982
BECTON, DICKINSON AND COMPANY1.18%72 711
HOYA CORPORATION30.69%62 143
ALIGN TECHNOLOGY, INC.35.72%57 302